SCHEMBL30543159

SCHEMBL30543159

FC(F)(F)c1cnc2[nH]ccc2c1Cl

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 3/20 0.57
▸ AXL P30530 2/20 0.57
▸ ULK1 O75385 6/20 0.41
▸ JAK1 P23458 3/20 0.39
▸ AURKA O14965 1/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ PRKCA P17252 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ NUDT1 P36639 2/20 0.37
▸ TTBK1 Q5TCY1 2/20 0.36
▸ TTBK2 Q6IQ55 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CDK8 P49336 1/20 0.36
▸ CCNK O75909 1/20 0.35
▸ CDK12 Q9NYV4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1467223 1.00 PRKCI (0.57) PRKCIAXLULK1JAK1AURKA
SCHEMBL10201641 0.83 PRKCI (0.62) PRKCIAXLJAK1AURKAJAK2
SCHEMBL18012903 0.83 PRKCI (0.49) PRKCIAXLULK1JAK1AURKA
SCHEMBL21855819 0.79 PRKCI (0.41) PRKCIAXLULK1JAK1AURKA
SCHEMBL21893423 0.79 ULK1 (0.47) PRKCIAXLULK1JAK1AURKA
SCHEMBL20243873 0.78 PRKCI (0.55) PRKCIAXLJAK1JAK2KDR
SCHEMBL24656163 0.77 PRKCI (0.42) PRKCIAXLULK1JAK1AURKA
SCHEMBL29431105 0.77 PRKCI (0.62) PRKCIAXLAURKAJAK2KDR
SCHEMBL1749025 0.77 PRKCI (0.62) PRKCIAXLAURKAJAK2KDR
SCHEMBL1356886 0.76 PRKCI (0.67) PRKCIAXLJAK1AURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114341124-B Protein tyrosine phosphatase inhibitors ARRAY生物制药公司 2024-09-20 — — CN disclosed
EP-4214199-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-07-26 — — EP disclosed
Send feedback